Sarah Turner

Sarah Hanson Turner serves as a procurement professional responsible for managing complex acquisitions in the scientific and technical services sector, with a strong emphasis on analytical instrumentation and diagnostic technologies. She plays a pivotal role in executing agency mission objectives through the strategic sourcing of high-precision laboratory equipment, in-vitro diagnostic substances, and specialized technical services. Her acquisitions align with federal requirements for performance-based contracting and are guided by rigorous technical evaluation criteria to ensure compliance with scientific and regulatory standards. Turner routinely handles sole-source, competitive, and sealed-bid procurements for mission-critical capabilities that support research, public health, and analytical testing operations. Her contractor relationships are primarily with manufacturers and service providers specializing in analytical laboratory instrumentation and diagnostic manufacturing, including firms with deep expertise in precision engineering and regulatory-compliant production environments. While no single contractor dominates her portfolio, she consistently engages with a network of mid-to-large-scale vendors capable of meeting stringent quality control and validation requirements. She also maintains a limited but intentional engagement with small businesses, particularly those certified under the Total Small Business Set-Aside program, fostering competition while ensuring technical capability. Turner’s contracting patterns reflect a strong preference for open competition, with 98% of awards issued without set-aside designations. Only 2% of her acquisitions are reserved for small businesses under FAR 19.5, indicating a focus on technical merit and capability over socioeconomic preferences. This reflects a mission-driven approach where specialized expertise and product performance take precedence over socioeconomic criteria. Her primary procurement focus lies in NAICS 334516 (Analytical Laboratory Instrument Manufacturing), followed by 811219 (Other Commercial and Industrial Machinery and Equipment Repair) and 325413 (In-Vitro Diagnostic Substance Manufacturing). She consistently acquires high-complexity equipment and reagents requiring FDA oversight, clinical validation, and calibration standards, demonstrating deep technical fluency in laboratory automation, diagnostic assay development, and scientific instrumentation lifecycle management.